ADCR has been granted 163 Chromates Authorisations in EU and UK


The ADCR Consortium was constituted in 2019 with over 60 members, with the aim to support the essential use of various chromates in the aerospace and defence sector. In 2022 and 2023 ADCR submitted the first tranche of dossiers (initial applications or review reports) and in 2025 tranche 2 was submitted. The tranches were submitted in both EU and UK.


Decisions on the dossiers have been granted by European Commission (in EU) and by Defra (in the UK/GB). In total the ADCR applicants have received 163 REACH Authorisation Numbers, where all decisions provide a 12-year review period (ranging from 2034 to 2038 depending on the application).


All decisions from EC and Defra are provided in an ADCR Communication found on the page ADCR Granted Authorisations. The latest version is ‘Summary of ADCR applications submitted in EU and GB and decisions status’ (pdf, version 14 May 2026).

Other news items:

19 November 2026
ECHA's Committee on Socio-economic Analysis (SEAC) adopted its final opinion on Cr(VI) restriction in their November meeting, and ECHA published news and extracts of action points today, 19 November 2026. SEAC concludes that the restriction options (RO1 and RO2) can be proportionate if the transitional period of 36 months for RO1, and longer than 36 months if RO2 are used. SEAC says that RO1 is having minor costs and very limited benefits and SEAC considers that RO2 is the option with the highest benefits that is still likely to be proportionate and practical. If a harmonised LV is preferred by the decision maker and distributional impacts are factored in by them, a uniform limit of 0.5 µg/m3 (in combination with ELVs of RO2) could also be an appropriate option. However, SEAC cannot come to a conclusion on whether a restriction is the most appropriate risk management option overall. ECHA has indicated that they will publish the opinion in the next few weeks. See ECHA news and extracts from the SEAC action points .
Show More